CD8A and cancer: The avidity of cancer-specific CD8+ T cells may be coupled to their polyfunctionality59, supporting the possibility that Lm-GUCY2C induces selective secondary expansion of high-avidity T cells with enhanced functionality and antitumor efficacy.